共 283 条
- [1] Parkin DM(2005)Global cancer statistics, 2002 CA Cancer J Clin 55 74-108
- [2] Bray F(2004)The curability of breast cancer and the treatment of advanced disease Eur J Nucl Med Mol Imaging 31 S149-S161
- [3] Ferlay J(1988)Combination adjuvant chemotherapy for node-positive breast cancer inadequacy of a single erioperative cycle N Engl J Med 319 677-683
- [4] Pisani P(1992)Systemic treatment of early breast cancer by hormonal cytotoxic or immune therapy 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women Lancet 339 1-15
- [5] Guarneri V(1998)Polychemotherapy for early breast cancer: an overview of the randomised trials Lancet 352 930-942
- [6] Conte PF(1995)Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks Mutat Res 330 115-181
- [7] Anderson D(2003)5-fluorouracil: mechanisms of action and clinical strategies Nat Rev Cancer 3 330-338
- [8] Bishop JB(2002)Assessment of chemotherapy-induced DNA damage in peripheral blood leukocytes of cancer patients using the alkaline comet assay Teratog Carcinog Mutagen 22 13-30
- [9] Colin Garner R(2006)Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients the FNCLCC PACS 01 Trial J Clin Oncol 24 5664-5671
- [10] Ostrosky-Wegman P(2006)Frequency and cost of chemotherapyrelated serious adverse effects in a population sample of women with breast cancer J Natl Cancer Inst 98 1108-1117